ES2089669T3 - Utilizacion de los derivados de isoquinolinona en el tratamiento de la hiperlipoproteinemia. - Google Patents

Utilizacion de los derivados de isoquinolinona en el tratamiento de la hiperlipoproteinemia.

Info

Publication number
ES2089669T3
ES2089669T3 ES93116125T ES93116125T ES2089669T3 ES 2089669 T3 ES2089669 T3 ES 2089669T3 ES 93116125 T ES93116125 T ES 93116125T ES 93116125 T ES93116125 T ES 93116125T ES 2089669 T3 ES2089669 T3 ES 2089669T3
Authority
ES
Spain
Prior art keywords
hyperlipoproteinemia
treatment
isoquinolinone derivatives
derivatives
isoquinolinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93116125T
Other languages
English (en)
Inventor
Motoharu Hasegawa
Kohji Shirai
Kiyohiko Matsumoto
Yasuhiko Suzuki
Isao Takahasi
Yuuiti Takarada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Application granted granted Critical
Publication of ES2089669T3 publication Critical patent/ES2089669T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL USO DE DERIVADOS DE ISOQUINOLINONA COMO UN AGENTE ANTIARTERIOESCLEROSIS Y ANTIHIPERLIPOPROTEINEMICOS. LOS DERIVADOS SON DE LA FORMULA, EN LA QUE R1 ES HIDROGENO O UN GRUPO ALQUILO C1 MOS FARMACEUTICAMENTE ACEPTABLES.
ES93116125T 1992-10-09 1993-10-06 Utilizacion de los derivados de isoquinolinona en el tratamiento de la hiperlipoproteinemia. Expired - Lifetime ES2089669T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04271480A JP3141051B2 (ja) 1992-10-09 1992-10-09 抗動脈硬化剤

Publications (1)

Publication Number Publication Date
ES2089669T3 true ES2089669T3 (es) 1996-10-01

Family

ID=17500634

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93116125T Expired - Lifetime ES2089669T3 (es) 1992-10-09 1993-10-06 Utilizacion de los derivados de isoquinolinona en el tratamiento de la hiperlipoproteinemia.

Country Status (7)

Country Link
US (1) US5441962A (es)
EP (1) EP0591937B1 (es)
JP (1) JP3141051B2 (es)
CA (1) CA2108065A1 (es)
DE (1) DE69302250T2 (es)
ES (1) ES2089669T3 (es)
TW (1) TW209168B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506325B1 (en) * 1999-02-05 2003-01-14 The B. F. Goodrich Company Method controlling the exotherm of a vacuum resin infusion
WO2004058717A1 (en) * 2002-12-20 2004-07-15 X-Ceptor Therapeutics, Inc. Isoquinolinone derivatives and their use as therapeutic agents
TWI499418B (zh) 2009-05-21 2015-09-11 Nerviano Medical Sciences Srl 異喹啉－１（２ｈ）－酮衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
JPS57212161A (en) * 1981-06-25 1982-12-27 Nisshin Flour Milling Co Ltd Isocarbostyril derivative
JPS6019715A (ja) * 1983-07-12 1985-01-31 Nisshin Flour Milling Co Ltd 安定なイソカルボスチリル製剤
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
HU202842B (en) * 1988-01-27 1991-04-29 May & Baker Ltd Process for producing new isoquinolinone derivatives and pharmaceutical compositions containing them
ES2075082T3 (es) * 1989-03-28 1995-10-01 Nisshin Flour Milling Co Derivados de isoquinolina para el tratamiento del glaucoma o hipertension ocular.
US5252583A (en) * 1989-03-28 1993-10-12 Nisshin Flour Milling Co., Ltd. Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension

Also Published As

Publication number Publication date
DE69302250D1 (de) 1996-05-23
EP0591937B1 (en) 1996-04-17
DE69302250T2 (de) 1996-09-19
JPH06116147A (ja) 1994-04-26
JP3141051B2 (ja) 2001-03-05
US5441962A (en) 1995-08-15
TW209168B (en) 1993-07-11
CA2108065A1 (en) 1994-04-10
EP0591937A1 (en) 1994-04-13

Similar Documents

Publication Publication Date Title
ES2188584T3 (es) Derivados heterociclicos de amina.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2195970T3 (es) L-ribavirina y usos de la misma.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
NL350077I1 (nl) Cyprosulfamide
NO962059L (no) Antiarytmiske benzodiazepiner
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
ES2179273T3 (es) N-bencil-2-fenilindolas como agentes estrogenicos.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
ATE166534T1 (de) Germicide wirkstoffkombinationen
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
ES2193508T3 (es) Ftalizinonas.
MX9700557A (es) Dihidrobenzofuranos.
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
ES2110260T3 (es) Androstenonas.
ES2189941T3 (es) Derivados de nucleosidos aciclicos.
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
ES2038127T3 (es) Procedimiento para preparar monosulfactamas.
AR025224A1 (es) Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 591937

Country of ref document: ES

FG2A Definitive protection

Ref document number: 591937

Country of ref document: ES